Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
2,399
self-reported band not used
Founded
1998
28 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Novell Pharmaceutical Laboratories was established in 1998 as a consequence of increasing globalisation and trend toward efficiency in the pharmaceutical industry.
In June 2011, Novell obtained its approval from Australian Therapeutic Goods Administration (TGA), in 2009 from GCC, in 2009 from South Africa MCC, in 2009 from UAE, in 2010 from Kenya and in 2011 from Turkey as a proof of its constant improvement in its quality process to ensure quality products for all its customers.
In 2013, Novell Pharma becomes the first Indonesian local pharma company to obtain GMP approval from European Union authority (Germany – Lageso) for its injectable plant. Novell also becomes the only company to have GMP license from Europe, Australia, South Africa PICS and GCC Gulf Countries.
In 2017 Novell becomes the first Indonesian company to obtain drug approval from EU Netherland Authority CBG/MEB.
As part of its international expansion, Novell has its own office and marketing team in the Philippines, Thailand and Vietnam.
Our Vision & Mission
It is the belief of the investors and the management team that private sectors should assist Government's mission to provide better quality healthcare products for the society. Novell concentrates on producing excellent quality high value added products to be consumed by patients as an alternative to the foreign imported high price products.
Besides developing its own products, Novell is actively searching for new products by partnering with other multinational companies to market their novel products which are needed by community. With international trend towards free trade and reducing healthcare expenditure, Novell is positioning itself as one of the worldwide providers for quality pharmaceutical products to international patients and partners.
Specialties
All 4 specialties
- Food supplement
- Cardiovascular & Hematopoietic System
- New and Innovative API
- and many other in lowest cost and high benefit
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | ID |
All codes: ID
Addresses
- IDJl. Pos Pengumben Raya 8; Jakarta, DKIPrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Novell Pharmaceutical Laboratories?
The record holds 2,399 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does Novell Pharmaceutical Laboratories have offices?
One address on record, Indonesia only. Primary: Jl. Pos Pengumben Raya 8, Jakarta, DKI.
Has Novell Pharmaceutical Laboratories raised funding?
None linked to this brand.
What does Novell Pharmaceutical Laboratories list as its specialties?
Four tags on the brand's own list, among them Food supplement, Cardiovascular & Hematopoietic System and New and Innovative API.
Which companies are listed alongside Novell Pharmaceutical Laboratories?
Eight peer profiles on record: ParagonCorp and Dexa Medica (Member of Dexa Group).